Class information for: |
Basic class information |
Class id | #P | Avg. number of references |
Database coverage of references |
---|---|---|---|
12959 | 869 | 32.3 | 80% |
Hierarchy of classes |
The table includes all classes above and classes immediately below the current class. |
Cluster id | Level | Cluster label | #P |
---|---|---|---|
7 | 4 | INFECTIOUS DISEASES//MICROBIOLOGY//VIROLOGY | 1353914 |
29 | 3 | HIV//VIROLOGY//HIV 1 | 108954 |
10 | 2 | AIDS RESEARCH AND HUMAN RETROVIRUSES//VIROLOGY//HIV 1 | 39664 |
12959 | 1 | HIV 2//HIV 2 INFECTION//GUINEA BISSAU | 869 |
Terms with highest relevance score |
rank | Term | termType | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|---|
1 | HIV 2 | authKW | 3039926 | 23% | 44% | 196 |
2 | HIV 2 INFECTION | authKW | 354297 | 1% | 92% | 11 |
3 | GUINEA BISSAU | authKW | 206731 | 4% | 18% | 32 |
4 | HUMAN IMMUNODEFICIENCY VIRUS TYPE 2 | authKW | 167409 | 1% | 53% | 9 |
5 | CLIN UNIV MED 2 | address | 132433 | 1% | 54% | 7 |
6 | CLIN MALAD INFECT IBRAHIMA DIOP MAR | address | 132272 | 1% | 47% | 8 |
7 | HOSP UNIV FANN | address | 126489 | 1% | 60% | 6 |
8 | UNIDADE IMUNOL CLIN | address | 76369 | 1% | 22% | 10 |
9 | CMG EC | address | 70274 | 0% | 100% | 2 |
10 | DUAL SEROREACTIVITY | authKW | 70274 | 0% | 100% | 2 |
Web of Science journal categories |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | Virology | 29840 | 44% | 0% | 386 |
2 | Infectious Diseases | 19340 | 44% | 0% | 385 |
3 | Immunology | 7034 | 43% | 0% | 376 |
4 | Medicine, General & Internal | 495 | 12% | 0% | 108 |
5 | Microbiology | 477 | 11% | 0% | 96 |
6 | Tropical Medicine | 355 | 3% | 0% | 28 |
7 | Public, Environmental & Occupational Health | 116 | 6% | 0% | 53 |
8 | Hematology | 34 | 3% | 0% | 24 |
9 | Biochemical Research Methods | 31 | 3% | 0% | 26 |
10 | Biotechnology & Applied Microbiology | 27 | 4% | 0% | 34 |
Address terms |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | CLIN UNIV MED 2 | 132433 | 1% | 54% | 7 |
2 | CLIN MALAD INFECT IBRAHIMA DIOP MAR | 132272 | 1% | 47% | 8 |
3 | HOSP UNIV FANN | 126489 | 1% | 60% | 6 |
4 | UNIDADE IMUNOL CLIN | 76369 | 1% | 22% | 10 |
5 | CMG EC | 70274 | 0% | 100% | 2 |
6 | SERV INFECT DIS MICROBIOL | 70274 | 0% | 100% | 2 |
7 | SERV MED TRANSFUS | 68859 | 1% | 28% | 7 |
8 | UNIDAD IMUNOL CLIN | 63244 | 0% | 60% | 3 |
9 | INVEST INTERDISCIPLINAR EGAS MONIZ CIIEM | 63238 | 1% | 30% | 6 |
10 | HIV PROGRAMME | 60226 | 1% | 29% | 6 |
Journals |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | AIDS | 69083 | 15% | 2% | 130 |
2 | AIDS RESEARCH AND HUMAN RETROVIRUSES | 43117 | 9% | 2% | 81 |
3 | JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES AND HUMAN RETROVIROLOGY | 16747 | 2% | 2% | 21 |
4 | JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES | 6492 | 2% | 1% | 18 |
5 | RETROVIROLOGY | 4141 | 1% | 1% | 12 |
6 | ANNALES DE L INSTITUT PASTEUR-VIROLOGY | 3064 | 0% | 2% | 4 |
7 | RESEARCH IN VIROLOGY | 2393 | 1% | 1% | 6 |
8 | JOURNAL OF HUMAN VIROLOGY | 1460 | 0% | 2% | 2 |
9 | JOURNAL OF VIROLOGICAL METHODS | 1428 | 2% | 0% | 17 |
10 | JOURNAL OF VIROLOGY | 1159 | 4% | 0% | 37 |
Author Key Words |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
LCSH search | Wikipedia search |
---|---|---|---|---|---|---|---|
1 | HIV 2 | 3039926 | 23% | 44% | 196 | Search HIV+2 | Search HIV+2 |
2 | HIV 2 INFECTION | 354297 | 1% | 92% | 11 | Search HIV+2+INFECTION | Search HIV+2+INFECTION |
3 | GUINEA BISSAU | 206731 | 4% | 18% | 32 | Search GUINEA+BISSAU | Search GUINEA+BISSAU |
4 | HUMAN IMMUNODEFICIENCY VIRUS TYPE 2 | 167409 | 1% | 53% | 9 | Search HUMAN+IMMUNODEFICIENCY+VIRUS+TYPE+2 | Search HUMAN+IMMUNODEFICIENCY+VIRUS+TYPE+2 |
5 | DUAL SEROREACTIVITY | 70274 | 0% | 100% | 2 | Search DUAL+SEROREACTIVITY | Search DUAL+SEROREACTIVITY |
6 | HIV 2 NATURAL HISTORY | 70274 | 0% | 100% | 2 | Search HIV+2+NATURAL+HISTORY | Search HIV+2+NATURAL+HISTORY |
7 | HIV 2 RNA | 70274 | 0% | 100% | 2 | Search HIV+2+RNA | Search HIV+2+RNA |
8 | HUMAN IMMUNODEFICIENCY VIRUS 1 AND VIRUS 2 | 70274 | 0% | 100% | 2 | Search HUMAN+IMMUNODEFICIENCY+VIRUS+1+AND+VIRUS+2 | Search HUMAN+IMMUNODEFICIENCY+VIRUS+1+AND+VIRUS+2 |
9 | QUANTITATIVE PLASMA HIV 2 RNA | 70274 | 0% | 100% | 2 | Search QUANTITATIVE+PLASMA+HIV+2+RNA | Search QUANTITATIVE+PLASMA+HIV+2+RNA |
10 | DUAL REACTIVITY | 52703 | 0% | 50% | 3 | Search DUAL+REACTIVITY | Search DUAL+REACTIVITY |
Core articles |
The table includes core articles in the class. The following variables is taken into account for the relevance score of an article in a cluster c: (1) Number of references referring to publications in the class. (2) Share of total number of active references referring to publications in the class. (3) Age of the article. New articles get higher score than old articles. (4) Citation rate, normalized to year. |
Rank | Reference | # ref. in cl. |
Shr. of ref. in cl. |
Citations |
---|---|---|---|---|
1 | VAN DER LOEFF, MFS , AABY, P , (1999) TOWARDS A BETTER UNDERSTANDING OF THE EPIDEMIOLOGY OF HIV-2.AIDS. VOL. 13. ISSUE . P. S69 -S84 | 97 | 76% | 67 |
2 | MENENDEZ-ARIAS, L , ALVAREZ, M , (2014) ANTIRETROVIRAL THERAPY AND DRUG RESISTANCE IN HUMAN IMMUNODEFICIENCY VIRUS TYPE 2 INFECTION.ANTIVIRAL RESEARCH. VOL. 102. ISSUE . P. 70-86 | 90 | 48% | 26 |
3 | NYAMWEYA, S , HEGEDUS, A , JAYE, A , ROWLAND-JONES, S , FLANAGAN, KL , MACALLAN, DC , (2013) COMPARING HIV-1 AND HIV-2 INFECTION: LESSONS FOR VIRAL IMMUNOPATHOGENESIS.REVIEWS IN MEDICAL VIROLOGY. VOL. 23. ISSUE 4. P. 221-240 | 63 | 67% | 27 |
4 | CAMPBELL-YESUFU, OT , GANDHI, RT , (2011) UPDATE ON HUMAN IMMUNODEFICIENCY VIRUS (HIV)-2 INFECTION.CLINICAL INFECTIOUS DISEASES. VOL. 52. ISSUE 6. P. 780 -787 | 46 | 92% | 50 |
5 | DE SILVA, TI , COTTEN, M , ROWLAND-JONES, SL , (2008) HIV-2: THE FORGOTTEN AIDS VIRUS.TRENDS IN MICROBIOLOGY. VOL. 16. ISSUE 12. P. 588-595 | 64 | 67% | 75 |
6 | GILLEECE, Y , CHADWICK, DR , BREUER, J , HAWKINS, D , SMIT, E , MCCRAE, LX , PILLAY, D , SMITH, N , ANDERSON, J , (2010) BRITISH HIV ASSOCIATION GUIDELINES FOR ANTIRETROVIRAL TREATMENT OF HIV-2-POSITIVE INDIVIDUALS 2010.HIV MEDICINE. VOL. 11. ISSUE 10. P. 611 -619 | 54 | 82% | 14 |
7 | ROWLAND-JONES, S , (2006) PROTECTIVE IMMUNITY AGAINST HIV INFECTION: LESSONS FROM HIV-2 INFECTION.FUTURE MICROBIOLOGY. VOL. 1. ISSUE 4. P. 427-433 | 51 | 86% | 6 |
8 | KANNANGAI, R , DAVID, S , SRIDHARAN, G , (2012) HUMAN IMMUNODEFICIENCY VIRUS TYPE-2-A MILDER, KINDER VIRUS: AN UPDATE.INDIAN JOURNAL OF MEDICAL MICROBIOLOGY. VOL. 30. ISSUE 1. P. 6 -15 | 47 | 76% | 2 |
9 | DRYLEWICZ, J , MATHERON, S , LAZARO, E , DAMOND, F , BONNET, F , SIMON, F , DABIS, F , BRUN-VEZINET, F , CHENE, G , THIEBAUT, R , (2008) COMPARISON OF VIRO-IMMUNOLOGICAL MARKER CHANGES BETWEEN HIV-1 AND HIV-2-INFECTED PATIENTS IN FRANCE.AIDS. VOL. 22. ISSUE 4. P. 457 -468 | 44 | 80% | 34 |
10 | VISSEAUX, B , DAMOND, F , MATHERON, S , DESCAMPS, D , CHARPENTIER, C , (2016) HIV-2 MOLECULAR EPIDEMIOLOGY.INFECTION GENETICS AND EVOLUTION. VOL. 46. ISSUE . P. 233 -240 | 45 | 61% | 0 |
Classes with closest relation at Level 1 |